At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NPCE NeuroPace Inc.
Pre-Market Trading 12-19 06:02:02 EST
10.64
-0.88
-7.64%
盘前11.13
+0.49+4.61%
04:48 EST
High12.23
Low9.92
Vol86.21K
Open11.69
D1 Closing11.52
Amplitude20.05%
Mkt Cap317.58M
Tradable Cap139.26M
Total Shares29.85M
T/O942.80K
T/O Rate0.66%
Tradable Shares13.09M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
NeuroPace Is Maintained at Overweight by JP Morgan
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.